Aveanna Healthcare Holdings Inc AVAH 深 滬
等待開盤 03-26 09:30:00 美东时间
6.62
+0.010
+0.15%
華盛通- 最 高6.74
- 今 開6.68
- 成交量 90.20万股
- 最 低 6.51
- 昨 收 6.61
- 總市值 13.84亿
- 52周最高 10.32
- 市盈率 靜 6.32
- 換手率 0.43%
- 52周最低 3.73
- 委 比 20.86%
- 總股本 2.09亿
- 歷史最高 13.00
- 量 比 0.42
- 振 幅 3.48%
- 歷史最低 0.6664
- 每 手 1
- 風險率 1.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
44分钟前
美股大行评级 | 瑞穗上调MongoDB至"跑赢大市"，目标价从290美元升至325美元；麦格理下调小鹏评级至"中性" 目标价从24美元降至19美元
今日重点评级关注：HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从12美元升至13美元；Litchfield Hills：维持Star Equity Holdings"买入"评级，目标价从21美元升至28美元
03-24 10:07
U.S. RESEARCH ROUNDUP- Arrivent Biopharma, Aveanna Healthcare Holdings, EQT
U.S. RESEARCH ROUNDUP- Arrivent Biopharma, Aveanna Healthcare Holdings, EQT March 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arrivent Biopharma, Aveanna Healthcare Holdings and EQT on Monday. HIGHLIGHTS * Arriven
03-23 15:35
美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Aveanna Issues 2026 Guidance and Growth Outlook
Aveanna Healthcare Holdings ( ($AVAH) ) just unveiled an update. Aveanna Health...
03-20 19:58
电话会总结 ｜ Aveanna(AVAH)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Aveanna Healthcare业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **整体业绩表现：** - **总营收**：第四季度营收6.62亿美元，同比增长27.4%；2025年全年营收24.33亿美元，同比增长20.2% - **调整后EBITDA**：第四季度8,500万美元，同比增长54%；2025年全年3.208亿美元，同比增长74.8% - **毛利润**：第四季度综合毛利润2.133亿美元，毛利率32.2% - **自由现金流**：第四季度1.31亿美元，表现强劲 **分业务板块表现：** - **私人护理服务(P
03-20 12:22
Aveanna outlines 2026 revenue target of $2.54B–$2.56B with eight new preferred payer agreements planned
Earnings Call Insights: Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Management View CEO Jeffrey Shaner highlighted a fourth quarter revenue of approximately $662 million, a 27.4% increase over the...
03-20 07:02
Aveanna Healthcare falls as revenue outlook trails consensus
Shares of Aveanna Healthcare (AVAH) dropped ~10% on Thursday, marking its biggest intraday decline in more than a year after the home healthcare provider, alongside its Q4 2025 results, issued a full-...
03-20 01:26
BUZZ-Aveanna falls after forecasting annual revenue slightly below estimates
BUZZ-Aveanna falls after forecasting annual revenue slightly below estimates ** Shares of home healthcare provider Aveanna Healthcare Holdings AVAH.O fall 8.97% to $6.29 ** Co expects FY26 revenue in the range of $2.54 billion to $2.56 billion, the mid-point of which is slightly below analysts' esti
03-19 22:09
Earnings Scheduled For March 19, 2026
Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to repo...
03-19 19:11
